Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jan
22
2015
Can Digital Healthcare Innovation Be Patented? Eligibility of Digital Healthcare Technologies Under the New USPTO Eligibility Guidelines Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jan
22
2015
Egypt and Blumberg Grain Launch World’s Largest Integrated Food Storage System Covington & Burling LLP
Jan
22
2015
Study Identifies Progress and Challenges in E-Prescribing Controlled Substances Covington & Burling LLP
Jan
22
2015
Goose Cooked? Foie Gras Producers Victorious, Sales and Marketing to Resume in California Morgan, Lewis & Bockius LLP
Jan
21
2015
New French Rules On Off-Label Use Covington & Burling LLP
Jan
21
2015
Teva v. Sandoz pt.II– The Dissent And The Zone Of Uncertainty
Jan
21
2015
Teva Pharmaceuticals v. Sandoz: Supreme Court Changes Standard of Review in Claim Construction Case Michael Best & Friedrich LLP
Jan
21
2015
Claim Construction in Patents: Teva v. Sandoz: “Just the facts, Ma’am”
Jan
20
2015
Giant Multinational Unilever Drops Suit Against Innovative Start-up Hampton Creek Over Eggless “Mayonnaise” Covington & Burling LLP
Jan
20
2015
FDA Issues Draft Guidance on Policy for Low Risk Devices for General Wellness Barnes & Thornburg LLP
Jan
20
2015
Myriad’s Fight Continues: Federal Circuit Finds Composition and Method Claims Ineligible Covington & Burling LLP
Jan
20
2015
Promega v. Life Technologies – “Too Much Of Nothing?” re: Patent Infringement
Jan
20
2015
CFDA Proposes New Regulations on the Accreditation of Medical Device Trial Sites: China Food and Drug Administration Covington & Burling LLP
Jan
19
2015
Washington Federal Judge Allows RCRA Citizen Suit Over Manure Management to Proceed--Resource Conservation and Recovery Act Michael Best & Friedrich LLP
Jan
16
2015
FDA Publishes Draft Guidances Describing General Wellness Claims and Risk-Based Classification of Accessories Covington & Burling LLP
Jan
16
2015
FDA Proposes to Apply Risk-Based Framework to Accessory Devices Mintz
Jan
16
2015
Fifth Circuit Holds That Product Development Protocol Has Same Preemptive Effect As Premarket Approval Covington & Burling LLP
Jan
15
2015
Pharmacy Qui Tam Based On U&C Price Billing Survives Motion to Dismiss Mintz
Jan
15
2015
CMS Releases EHR (Electronic Health Records) Incentive Program Data Covington & Burling LLP
Jan
14
2015
Torrent Pharmaceuticals Limited v. Merck Frosst Canada & Co.: Denying Petitioner’s Request for Rehearing of Decision on Institution IPR2014-00559 Faegre Drinker
Jan
14
2015
New Jersey Pharmaceutical Company Agrees to Pay $39 Million to Settle Alleged Anti-Kickback Violations Tycko & Zavareei LLP
Jan
14
2015
Latest Proposal to Repeal Medical Device Excise Tax Gains Traction Covington & Burling LLP
Jan
13
2015
CDRH Releases 2015 Guidance Document Agenda, Announces Retrospective Guidance Document Review -- Center for Devices and Radiological Health Covington & Burling LLP
Jan
12
2015
FDA Issues Draft Guidance on Transfer of a 510(k) Clearance Barnes & Thornburg LLP
Jan
12
2015
Inching Closer to the First Biosimilar Approval in the U.S. Michael Best & Friedrich LLP
Jan
9
2015
FDA Is Exploring Options for Regulating Next Generation Sequencing Diagnostic Tests Covington & Burling LLP
Jan
9
2015
Second Circuit To Hear Expedited Appeal in “Product Hopping” Suit McDermott Will & Emery
Jan
8
2015
FDA Issues Draft Guidance on 510(k) Transfers Covington & Burling LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins